BD Discardit 2ml Syringe with 21g Needle - each
847197
This 2ml syringe with an attached 21-gauge (21g) needle is suitable for administering specific medications to cats and dogs that require subcutaneous injections. Each syringe is individually packaged, sterile, and designed for single use only. This product is commonly used in veterinary practices and at home under veterinary guidance.
The syringe has a 2ml capacity and is fitted with a 21g needle. This needle size is considered suitable for administering certain subcutaneous or intramuscular injections in cats and dogs, depending on the medication and the animal’s size and condition. The 21g needle offers a balance between needle strength and minimal discomfort during injection, making it appropriate for routine use with specific veterinary biologics.
This type of syringe is appropriate for administering Solensia, Librela, and Cytopoint, which are injectable monoclonal antibody therapies used to manage chronic pain and allergic dermatitis in pets. These medications are typically prescribed for monthly administration and are given via subcutaneous injection. The 21g needle provides a suitable gauge for delivering the full dose efficiently while maintaining comfort for the animal.
Solensia is prescribed for the management of osteoarthritis pain in cats. It is given once a month via subcutaneous injection. The 2ml syringe allows for accurate dosing, and the 21g needle is appropriate for the viscosity of the Solensia solution and for delivering it under the skin in a cat with minimal stress and tissue trauma.
Librela is used in dogs to treat pain associated with osteoarthritis. Like Solensia, it is administered subcutaneously once a month. The 21g needle is appropriate for most dog breeds and sizes, as it enables smooth delivery of the medication while being strong enough to penetrate the skin effectively without bending or breaking.
Cytopoint is another monoclonal antibody therapy, used to manage allergic dermatitis in dogs. It is also given as a monthly subcutaneous injection. The 2ml capacity of the syringe provides ample volume to accommodate the required dose, and the 21g needle is compatible with the formulation’s consistency and administration method.
This syringe and needle combination should not be used for insulin administration in cats or dogs. Veterinary insulin products such as Caninsulin and Prozinc require specific insulin syringes that are calibrated differently from standard 2ml syringes. Insulin syringes are typically marked in units, not millilitres, and have finer, shorter needles such as 29g or 30g, which are designed to deliver precise insulin doses in small volumes. Using a standard 2ml syringe for insulin injections can lead to inaccurate dosing and can be dangerous to the animal.
More Information
Description
Caninsulin and Prozinc are insulins specifically formulated for veterinary use and have unique concentration requirements—Caninsulin, for example, is 40 IU/ml, which is incompatible with syringes calibrated for human insulin (100 IU/ml). Insulin syringes are essential for these medications to ensure proper dosing and to reduce the risk of hypoglycaemia or underdosing. The 21g needle on this syringe is also too large and inappropriate for the fine control needed with insulin injections.
The 2ml syringe with 21g needle is equipped with clear volume markings along the barrel, which helps ensure accurate dose measurement. The plunger moves smoothly within the barrel, allowing for controlled and consistent administration of medication. The syringe and needle are securely attached, reducing the risk of detachment during use.
The syringe is made from medical-grade materials that comply with health and safety standards for veterinary injections. It is intended for single-use to prevent contamination and cross-infection. After use, syringes should be disposed of safely in an appropriate sharps container, in accordance with local veterinary or environmental guidelines.
These syringes are commonly used in both professional veterinary settings and for home administration by pet owners, following instruction from a veterinary surgeon. Handling instructions and injection techniques should always be followed as advised by the prescribing professional. Administering injectable medications without proper training or guidance is not recommended.
You may also like
15mg Librela Solution for Dogs - 2 Vials
15mg Librela is an innovative drug for the alleviation of pain associated with osteoarthritis in dogs.
Librela 15mg is a revolutionary solution that provides effective relief from osteoarthritis pain in dogs, with a safety profile supported by studies. It differs from traditional NSAIDs by specifically targeting Nerve Growth Factor (NGF), an essential cause of osteoarthritis pain.
Librela is a refrigerated medication - We will send it via Royal Mail Special Delivery using insulated packaging and ice packs. A signature is required on delivery and it must be put straight into a fridge. We cannot guarantee same day dispatch for orders placed after 12pm. VETERINARY PRESCRIPTION REQUIRED.
Librela is a monoclonal antibody, replicating the function of naturally occurring antibodies. It is removed via standard protein degradation pathways, resulting in a low-impact treatment on the liver or kidneys and minimal gastrointestinal effects. Clinical studies indicate increased mobility and reduced pain in dogs after the initial Librela injection.
20mg Librela Solution for Dogs - 2 Vials
Librela 20mg is a novel solution in osteoarthritis pain relief for dogs that's scientifically proven to ease pain effectively for an entire month. With minimal liver, kidney, and GI involvement, Librela's monoclonal antibodies offer a safer, more natural approach to treating osteoarthritis in dogs.
Designed as a monthly injection, Librela provides an innovative alternative to NSAIDs by targeting the Nerve Growth Factor (NGF), known for inducing pain and inflammation in osteoarthritis. Dogs show a marked increase in mobility and reduction in pain after the first dose, making it an ideal choice for pain management.
20mg Librela is an innovative drug for the alleviation of pain associated with osteoarthritis in dogs. Osteoarthritis in dogs is a common disease and has been associated with pain.
Librela is a refrigerated medication - We will send it via Royal Mail Special Delivery using insulated packaging and ice packs. A signature is required on delivery and it must be put straight into a fridge. We cannot guarantee same day dispatch for orders placed after 12pm. VETERINARY PRESCRIPTION REQUIRED.
Librela 20mg is a caninised monoclonal antibody. Each vial of 1ml Librela contains 20mg bedinvetmab and enhances the natural process of clearing away immune complexes, thus avoiding pain signals from reaching the brain and causing neuropathic pain.
30mg Librela Solution for Dogs - 2 Vials
30mg Librela is an innovative drug for the alleviation of pain associated with osteoarthritis in dogs.
Librela 30mg innovative solution uses monoclonal antibodies to target and neutralize Nerve Growth Factor (NGF), a leading cause of osteoarthritis pain. By working differently from NSAIDs, Librela offers a month-long relief from pain with minimal involvement of liver or kidneys and with few GI side effects.
Librela is a refrigerated medication - We will send it via Royal Mail Special Delivery using insulated packaging and ice packs. A signature is required on delivery and it must be put straight into a fridge. We cannot guarantee same day dispatch for orders placed after 12pm. VETERINARY PRESCRIPTION REQUIRED.
With four out of ten dogs showing clinical signs of osteoarthritis, Librela is a leap forward in disease management. Whether you're a pet owner seeking the convenience of a monthly injection or have a pet with intermittent pain or difficulty taking oral doses, Librela could be the answer. Early detection and proactive pain management can help improve the lives of dogs affected by this common disease. Choose Librela - because every dog deserves a pain-free life.
Solensia for Cats - 7mg/ml - Pack of 2
Solensia is a prescription medication used to manage osteoarthritis pain in cats. It contains frunevetmab, a monoclonal antibody designed to target and block nerve growth factor (NGF), a key driver of osteoarthritic pain. Solensia is administered as a monthly injection by a veterinarian to provide long-term relief from joint pain and discomfort.
Solensia is a refrigerated medication - We will send it via Royal Mail Special Delivery using insulated packaging and ice packs. A signature is required on delivery and it must be put straight into a fridge. We cannot guarantee same day dispatch for orders placed after 12pm. VETERINARY PRESCRIPTION REQUIRED.
Osteoarthritis is a common but often undiagnosed condition in older cats. Solensia helps improve mobility, reduce pain, and enhance a cat’s overall quality of life. Unlike traditional pain medications, Solensia is specifically designed for long-term use with minimal side effects.
How Solensia Works
Solensia contains frunevetmab, a monoclonal antibody that targets NGF, a protein involved in pain signalling. In cats with osteoarthritis, NGF levels are elevated, leading to increased pain sensitivity and joint discomfort.
By binding to NGF, Solensia prevents it from interacting with pain receptors in the nervous system. This reduces pain transmission and helps control the chronic discomfort associated with osteoarthritis. Since monoclonal antibodies function like natural proteins, they are gradually broken down by the body without placing strain on the liver or kidneys.
Solensia provides continuous pain relief for up to one month, making it a convenient option for cats who struggle with daily oral medications.